Bristol Myers Squibb (BMY) Interest & Investment Income (2009 - 2025)

Bristol Myers Squibb (BMY) has reported Interest & Investment Income for 8 consecutive years, with $566.0 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Interest & Investment Income fell 12.65% year-over-year to $566.0 million in Q4 2025; TTM through Dec 2025 was $566.0 million, a 12.65% decrease from a year earlier, with the FY2025 full-year figure at $566.0 million, down 12.65% from the prior year.
• Interest & Investment Income was $566.0 million for Q4 2025 at Bristol Myers Squibb, down from $648.0 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $768.0 million in Q4 2021 and troughed at $566.0 million in Q4 2025.
• A 5-year average of $668.6 million and a median of $648.0 million in 2024 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income retreated 18.88% in 2022 and rose 18.46% in 2023, its largest moves.
• Over 5 years, Interest & Investment Income stood at $768.0 million in 2021, then dropped by 18.88% to $623.0 million in 2022, then advanced by 18.46% to $738.0 million in 2023, then decreased by 12.2% to $648.0 million in 2024, then fell by 12.65% to $566.0 million in 2025.
• The last three Interest & Investment Income figures came in at $566.0 million (Q4 2025), $648.0 million (Q4 2024), and $738.0 million (Q4 2023), per Business Quant data.